The “CRISPR-Cas9 model” is genetically representative of a common human rod-cone dystrophy as with this technique we specifically ablate a frequently mutated gene in rods by editing the Rhodopsin gene similar to the RHO mutation in human disease. This evidence concerns the gene RHO and cone-rod dystrophy.